News Related to 4-1BB Ligand

Related coverage linked through entity extraction aliases.

CAR-T Cell Advances Target Solid Tumors and Blood Cancers with New Strategies

Feb 27, 2026

Researchers develop ultra-sensitive CAR-T cells targeting CD70 for solid tumors and KRASG12V/HLA-A*02:01-specific CAR-T cells for cancers with KRAS mutations, demonstrating efficacy in preclinical models.

Ankyra Therapeutics Presents Preclinical Data on ANK-203 CD137-Anchored Immunotherapy

Feb 19, 2026

Ankyra Therapeutics announced preclinical data on ANK-203, a first-in-class anchored immunotherapy using monoclonal antibody CD137, showing strong anti-tumor activity with no observed systemic toxicity at the AACR Immuno-Oncology Conference.